nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—Alkylating Activity—Temozolomide—skin cancer	0.48	0.556	CiPCiCtD
Mitomycin—Alkylating Activity—Dacarbazine—skin cancer	0.384	0.444	CiPCiCtD
Mitomycin—ABCB1—Vismodegib—skin cancer	0.037	0.557	CbGbCtD
Mitomycin—ABCB1—Dactinomycin—skin cancer	0.0194	0.292	CbGbCtD
Mitomycin—Fraction of inspired oxygen—Bleomycin—skin cancer	0.0132	0.191	CcSEcCtD
Mitomycin—ABCB1—Docetaxel—skin cancer	0.01	0.151	CbGbCtD
Mitomycin—Dry cough—Bleomycin—skin cancer	0.00296	0.0427	CcSEcCtD
Mitomycin—Metastatic disease—Docetaxel—skin cancer	0.00223	0.0321	CcSEcCtD
Mitomycin—Metastatic neoplasm—Temozolomide—skin cancer	0.00201	0.029	CcSEcCtD
Mitomycin—Cardiotoxicity—Fluorouracil—skin cancer	0.00151	0.0218	CcSEcCtD
Mitomycin—Metastatic neoplasm—Docetaxel—skin cancer	0.00134	0.0193	CcSEcCtD
Mitomycin—Cardiotoxicity—Docetaxel—skin cancer	0.00109	0.0157	CcSEcCtD
Mitomycin—Acute respiratory distress syndrome—Docetaxel—skin cancer	0.000984	0.0142	CcSEcCtD
Mitomycin—Myelosuppression—Bleomycin—skin cancer	0.000976	0.0141	CcSEcCtD
Mitomycin—Lung infiltration—Bleomycin—skin cancer	0.000976	0.0141	CcSEcCtD
Mitomycin—Myelosuppression—Dactinomycin—skin cancer	0.000911	0.0131	CcSEcCtD
Mitomycin—Myelosuppression—Temozolomide—skin cancer	0.000824	0.0119	CcSEcCtD
Mitomycin—Nephropathy toxic—Bleomycin—skin cancer	0.000797	0.0115	CcSEcCtD
Mitomycin—Stinging—Imiquimod—skin cancer	0.000796	0.0115	CcSEcCtD
Mitomycin—Myelosuppression—Fluorouracil—skin cancer	0.000759	0.0109	CcSEcCtD
Mitomycin—Ulcer—Imiquimod—skin cancer	0.000681	0.00982	CcSEcCtD
Mitomycin—Pulmonary oedema—Imiquimod—skin cancer	0.000574	0.00827	CcSEcCtD
Mitomycin—Myelosuppression—Docetaxel—skin cancer	0.000548	0.0079	CcSEcCtD
Mitomycin—Necrosis—Dactinomycin—skin cancer	0.000544	0.00784	CcSEcCtD
Mitomycin—Alopecia—Vismodegib—skin cancer	0.000543	0.00783	CcSEcCtD
Mitomycin—Extravasation—Bleomycin—skin cancer	0.000525	0.00757	CcSEcCtD
Mitomycin—Extravasation—Dactinomycin—skin cancer	0.000489	0.00706	CcSEcCtD
Mitomycin—Ulcer—Bleomycin—skin cancer	0.000484	0.00698	CcSEcCtD
Mitomycin—Necrosis—Fluorouracil—skin cancer	0.000453	0.00654	CcSEcCtD
Mitomycin—Ulcer—Dactinomycin—skin cancer	0.000451	0.00651	CcSEcCtD
Mitomycin—Stinging—Fluorouracil—skin cancer	0.000439	0.00633	CcSEcCtD
Mitomycin—Extravasation—Fluorouracil—skin cancer	0.000408	0.00588	CcSEcCtD
Mitomycin—Pancytopenia—Imiquimod—skin cancer	0.000384	0.00554	CcSEcCtD
Mitomycin—Decreased appetite—Vismodegib—skin cancer	0.000379	0.00547	CcSEcCtD
Mitomycin—Fatigue—Vismodegib—skin cancer	0.000376	0.00542	CcSEcCtD
Mitomycin—Ulcer—Fluorouracil—skin cancer	0.000376	0.00542	CcSEcCtD
Mitomycin—Pain—Vismodegib—skin cancer	0.000373	0.00538	CcSEcCtD
Mitomycin—Burning sensation—Docetaxel—skin cancer	0.00037	0.00533	CcSEcCtD
Mitomycin—Alopecia—Vemurafenib—skin cancer	0.000335	0.00483	CcSEcCtD
Mitomycin—Erythema—Vemurafenib—skin cancer	0.00033	0.00476	CcSEcCtD
Mitomycin—Necrosis—Docetaxel—skin cancer	0.000327	0.00472	CcSEcCtD
Mitomycin—Thrombophlebitis—Temozolomide—skin cancer	0.000324	0.00467	CcSEcCtD
Mitomycin—Asthenia—Vismodegib—skin cancer	0.000313	0.00451	CcSEcCtD
Mitomycin—Diarrhoea—Vismodegib—skin cancer	0.000299	0.0043	CcSEcCtD
Mitomycin—Thrombophlebitis—Fluorouracil—skin cancer	0.000298	0.0043	CcSEcCtD
Mitomycin—Extravasation—Docetaxel—skin cancer	0.000294	0.00424	CcSEcCtD
Mitomycin—Cough—Vemurafenib—skin cancer	0.000288	0.00416	CcSEcCtD
Mitomycin—Alopecia—Imiquimod—skin cancer	0.000286	0.00412	CcSEcCtD
Mitomycin—Erythema—Imiquimod—skin cancer	0.000282	0.00406	CcSEcCtD
Mitomycin—Vomiting—Vismodegib—skin cancer	0.000277	0.004	CcSEcCtD
Mitomycin—Rash—Vismodegib—skin cancer	0.000275	0.00397	CcSEcCtD
Mitomycin—Dermatitis—Vismodegib—skin cancer	0.000275	0.00396	CcSEcCtD
Mitomycin—Pancytopenia—Bleomycin—skin cancer	0.000273	0.00393	CcSEcCtD
Mitomycin—Ill-defined disorder—Imiquimod—skin cancer	0.000261	0.00377	CcSEcCtD
Mitomycin—Nausea—Vismodegib—skin cancer	0.000259	0.00374	CcSEcCtD
Mitomycin—Injection site reaction—Docetaxel—skin cancer	0.000255	0.00368	CcSEcCtD
Mitomycin—Pancytopenia—Dactinomycin—skin cancer	0.000254	0.00367	CcSEcCtD
Mitomycin—Malaise—Imiquimod—skin cancer	0.000254	0.00366	CcSEcCtD
Mitomycin—Syncope—Imiquimod—skin cancer	0.000253	0.00364	CcSEcCtD
Mitomycin—Stomatitis—Bleomycin—skin cancer	0.00025	0.0036	CcSEcCtD
Mitomycin—Loss of consciousness—Imiquimod—skin cancer	0.000248	0.00357	CcSEcCtD
Mitomycin—Cough—Imiquimod—skin cancer	0.000246	0.00354	CcSEcCtD
Mitomycin—Hypertension—Imiquimod—skin cancer	0.000243	0.00351	CcSEcCtD
Mitomycin—Discomfort—Imiquimod—skin cancer	0.000237	0.00342	CcSEcCtD
Mitomycin—Decreased appetite—Vemurafenib—skin cancer	0.000234	0.00338	CcSEcCtD
Mitomycin—Stomatitis—Dactinomycin—skin cancer	0.000233	0.00336	CcSEcCtD
Mitomycin—Fatigue—Vemurafenib—skin cancer	0.000232	0.00335	CcSEcCtD
Mitomycin—Pancytopenia—Temozolomide—skin cancer	0.00023	0.00332	CcSEcCtD
Mitomycin—Oedema—Imiquimod—skin cancer	0.00023	0.00331	CcSEcCtD
Mitomycin—Pulmonary oedema—Docetaxel—skin cancer	0.000229	0.0033	CcSEcCtD
Mitomycin—Shock—Imiquimod—skin cancer	0.000226	0.00326	CcSEcCtD
Mitomycin—Anorexia—Imiquimod—skin cancer	0.000219	0.00316	CcSEcCtD
Mitomycin—Thrombophlebitis—Docetaxel—skin cancer	0.000215	0.00311	CcSEcCtD
Mitomycin—Body temperature increased—Vemurafenib—skin cancer	0.000213	0.00307	CcSEcCtD
Mitomycin—Pancytopenia—Fluorouracil—skin cancer	0.000212	0.00306	CcSEcCtD
Mitomycin—Stomatitis—Temozolomide—skin cancer	0.000211	0.00304	CcSEcCtD
Mitomycin—Cardiac failure congestive—Docetaxel—skin cancer	0.000206	0.00296	CcSEcCtD
Mitomycin—Dyspnoea—Imiquimod—skin cancer	0.000205	0.00296	CcSEcCtD
Mitomycin—Somnolence—Imiquimod—skin cancer	0.000204	0.00295	CcSEcCtD
Mitomycin—Alopecia—Bleomycin—skin cancer	0.000203	0.00293	CcSEcCtD
Mitomycin—Erythema—Bleomycin—skin cancer	0.0002	0.00289	CcSEcCtD
Mitomycin—Decreased appetite—Imiquimod—skin cancer	0.0002	0.00288	CcSEcCtD
Mitomycin—Fatigue—Imiquimod—skin cancer	0.000198	0.00286	CcSEcCtD
Mitomycin—Pain—Imiquimod—skin cancer	0.000197	0.00283	CcSEcCtD
Mitomycin—Renal impairment—Docetaxel—skin cancer	0.000196	0.00282	CcSEcCtD
Mitomycin—Stomatitis—Fluorouracil—skin cancer	0.000194	0.0028	CcSEcCtD
Mitomycin—Asthenia—Vemurafenib—skin cancer	0.000193	0.00279	CcSEcCtD
Mitomycin—Alopecia—Dactinomycin—skin cancer	0.000189	0.00273	CcSEcCtD
Mitomycin—Feeling abnormal—Imiquimod—skin cancer	0.000189	0.00273	CcSEcCtD
Mitomycin—Erythema—Dactinomycin—skin cancer	0.000187	0.00269	CcSEcCtD
Mitomycin—Ill-defined disorder—Bleomycin—skin cancer	0.000186	0.00268	CcSEcCtD
Mitomycin—Anaemia—Bleomycin—skin cancer	0.000185	0.00267	CcSEcCtD
Mitomycin—Diarrhoea—Vemurafenib—skin cancer	0.000184	0.00266	CcSEcCtD
Mitomycin—Body temperature increased—Imiquimod—skin cancer	0.000182	0.00262	CcSEcCtD
Mitomycin—Malaise—Bleomycin—skin cancer	0.00018	0.0026	CcSEcCtD
Mitomycin—Leukopenia—Bleomycin—skin cancer	0.000179	0.00258	CcSEcCtD
Mitomycin—Dizziness—Vemurafenib—skin cancer	0.000178	0.00257	CcSEcCtD
Mitomycin—Cough—Bleomycin—skin cancer	0.000175	0.00252	CcSEcCtD
Mitomycin—Ill-defined disorder—Dactinomycin—skin cancer	0.000173	0.0025	CcSEcCtD
Mitomycin—Anaemia—Dactinomycin—skin cancer	0.000173	0.00249	CcSEcCtD
Mitomycin—Vomiting—Vemurafenib—skin cancer	0.000171	0.00247	CcSEcCtD
Mitomycin—Alopecia—Temozolomide—skin cancer	0.000171	0.00247	CcSEcCtD
Mitomycin—Rash—Vemurafenib—skin cancer	0.00017	0.00245	CcSEcCtD
Mitomycin—Dermatitis—Vemurafenib—skin cancer	0.00017	0.00245	CcSEcCtD
Mitomycin—Headache—Vemurafenib—skin cancer	0.000169	0.00244	CcSEcCtD
Mitomycin—Erythema—Temozolomide—skin cancer	0.000169	0.00243	CcSEcCtD
Mitomycin—Discomfort—Bleomycin—skin cancer	0.000168	0.00243	CcSEcCtD
Mitomycin—Malaise—Dactinomycin—skin cancer	0.000168	0.00243	CcSEcCtD
Mitomycin—Leukopenia—Dactinomycin—skin cancer	0.000167	0.00241	CcSEcCtD
Mitomycin—Asthenia—Imiquimod—skin cancer	0.000165	0.00238	CcSEcCtD
Mitomycin—Confusional state—Bleomycin—skin cancer	0.000165	0.00237	CcSEcCtD
Mitomycin—Oedema—Bleomycin—skin cancer	0.000163	0.00236	CcSEcCtD
Mitomycin—Nausea—Vemurafenib—skin cancer	0.00016	0.00231	CcSEcCtD
Mitomycin—Thrombocytopenia—Bleomycin—skin cancer	0.00016	0.00231	CcSEcCtD
Mitomycin—Vision blurred—Temozolomide—skin cancer	0.000159	0.00229	CcSEcCtD
Mitomycin—Alopecia—Fluorouracil—skin cancer	0.000158	0.00228	CcSEcCtD
Mitomycin—Diarrhoea—Imiquimod—skin cancer	0.000157	0.00227	CcSEcCtD
Mitomycin—Discomfort—Dactinomycin—skin cancer	0.000157	0.00226	CcSEcCtD
Mitomycin—Ill-defined disorder—Temozolomide—skin cancer	0.000157	0.00226	CcSEcCtD
Mitomycin—Anaemia—Temozolomide—skin cancer	0.000156	0.00225	CcSEcCtD
Mitomycin—Anorexia—Bleomycin—skin cancer	0.000156	0.00224	CcSEcCtD
Mitomycin—Erythema—Fluorouracil—skin cancer	0.000156	0.00224	CcSEcCtD
Mitomycin—Pancytopenia—Docetaxel—skin cancer	0.000153	0.00221	CcSEcCtD
Mitomycin—Oedema—Dactinomycin—skin cancer	0.000152	0.0022	CcSEcCtD
Mitomycin—Malaise—Temozolomide—skin cancer	0.000152	0.0022	CcSEcCtD
Mitomycin—Dizziness—Imiquimod—skin cancer	0.000152	0.00219	CcSEcCtD
Mitomycin—Leukopenia—Temozolomide—skin cancer	0.000151	0.00218	CcSEcCtD
Mitomycin—Thrombocytopenia—Dactinomycin—skin cancer	0.000149	0.00215	CcSEcCtD
Mitomycin—Cough—Temozolomide—skin cancer	0.000147	0.00212	CcSEcCtD
Mitomycin—Vision blurred—Fluorouracil—skin cancer	0.000147	0.00211	CcSEcCtD
Mitomycin—Vomiting—Imiquimod—skin cancer	0.000146	0.00211	CcSEcCtD
Mitomycin—Hypertension—Temozolomide—skin cancer	0.000146	0.0021	CcSEcCtD
Mitomycin—Dyspnoea—Bleomycin—skin cancer	0.000146	0.0021	CcSEcCtD
Mitomycin—Anorexia—Dactinomycin—skin cancer	0.000145	0.00209	CcSEcCtD
Mitomycin—Rash—Imiquimod—skin cancer	0.000145	0.00209	CcSEcCtD
Mitomycin—Dermatitis—Imiquimod—skin cancer	0.000145	0.00209	CcSEcCtD
Mitomycin—Headache—Imiquimod—skin cancer	0.000144	0.00208	CcSEcCtD
Mitomycin—Anaemia—Fluorouracil—skin cancer	0.000144	0.00207	CcSEcCtD
Mitomycin—Discomfort—Temozolomide—skin cancer	0.000142	0.00205	CcSEcCtD
Mitomycin—Decreased appetite—Bleomycin—skin cancer	0.000142	0.00205	CcSEcCtD
Mitomycin—Renal failure—Docetaxel—skin cancer	0.000141	0.00204	CcSEcCtD
Mitomycin—Stomatitis—Docetaxel—skin cancer	0.00014	0.00202	CcSEcCtD
Mitomycin—Pain—Bleomycin—skin cancer	0.00014	0.00201	CcSEcCtD
Mitomycin—Leukopenia—Fluorouracil—skin cancer	0.000139	0.00201	CcSEcCtD
Mitomycin—Confusional state—Temozolomide—skin cancer	0.000139	0.002	CcSEcCtD
Mitomycin—Oedema—Temozolomide—skin cancer	0.000138	0.00199	CcSEcCtD
Mitomycin—Nausea—Imiquimod—skin cancer	0.000137	0.00197	CcSEcCtD
Mitomycin—Thrombocytopenia—Temozolomide—skin cancer	0.000135	0.00195	CcSEcCtD
Mitomycin—Feeling abnormal—Bleomycin—skin cancer	0.000135	0.00194	CcSEcCtD
Mitomycin—Decreased appetite—Dactinomycin—skin cancer	0.000132	0.00191	CcSEcCtD
Mitomycin—Fatigue—Dactinomycin—skin cancer	0.000131	0.00189	CcSEcCtD
Mitomycin—Anorexia—Temozolomide—skin cancer	0.000131	0.00189	CcSEcCtD
Mitomycin—Discomfort—Fluorouracil—skin cancer	0.000131	0.00189	CcSEcCtD
Mitomycin—Pain—Dactinomycin—skin cancer	0.00013	0.00188	CcSEcCtD
Mitomycin—Body temperature increased—Bleomycin—skin cancer	0.000129	0.00186	CcSEcCtD
Mitomycin—Confusional state—Fluorouracil—skin cancer	0.000128	0.00185	CcSEcCtD
Mitomycin—Oedema—Fluorouracil—skin cancer	0.000127	0.00183	CcSEcCtD
Mitomycin—Feeling abnormal—Dactinomycin—skin cancer	0.000126	0.00181	CcSEcCtD
Mitomycin—Thrombocytopenia—Fluorouracil—skin cancer	0.000124	0.00179	CcSEcCtD
Mitomycin—Dyspnoea—Temozolomide—skin cancer	0.000123	0.00177	CcSEcCtD
Mitomycin—Somnolence—Temozolomide—skin cancer	0.000122	0.00177	CcSEcCtD
Mitomycin—Anorexia—Fluorouracil—skin cancer	0.000121	0.00174	CcSEcCtD
Mitomycin—Body temperature increased—Dactinomycin—skin cancer	0.00012	0.00174	CcSEcCtD
Mitomycin—Decreased appetite—Temozolomide—skin cancer	0.00012	0.00173	CcSEcCtD
Mitomycin—Fatigue—Temozolomide—skin cancer	0.000119	0.00171	CcSEcCtD
Mitomycin—Pain—Temozolomide—skin cancer	0.000118	0.0017	CcSEcCtD
Mitomycin—Asthenia—Bleomycin—skin cancer	0.000117	0.00169	CcSEcCtD
Mitomycin—Alopecia—Docetaxel—skin cancer	0.000114	0.00164	CcSEcCtD
Mitomycin—Feeling abnormal—Temozolomide—skin cancer	0.000114	0.00164	CcSEcCtD
Mitomycin—Dyspnoea—Fluorouracil—skin cancer	0.000113	0.00163	CcSEcCtD
Mitomycin—Somnolence—Fluorouracil—skin cancer	0.000113	0.00163	CcSEcCtD
Mitomycin—Erythema—Docetaxel—skin cancer	0.000112	0.00162	CcSEcCtD
Mitomycin—Decreased appetite—Fluorouracil—skin cancer	0.00011	0.00159	CcSEcCtD
Mitomycin—Asthenia—Dactinomycin—skin cancer	0.000109	0.00158	CcSEcCtD
Mitomycin—Body temperature increased—Temozolomide—skin cancer	0.000109	0.00157	CcSEcCtD
Mitomycin—Pain—Fluorouracil—skin cancer	0.000109	0.00157	CcSEcCtD
Mitomycin—Feeling abnormal—Fluorouracil—skin cancer	0.000105	0.00151	CcSEcCtD
Mitomycin—Diarrhoea—Dactinomycin—skin cancer	0.000104	0.0015	CcSEcCtD
Mitomycin—Vomiting—Bleomycin—skin cancer	0.000104	0.0015	CcSEcCtD
Mitomycin—Anaemia—Docetaxel—skin cancer	0.000104	0.0015	CcSEcCtD
Mitomycin—Rash—Bleomycin—skin cancer	0.000103	0.00148	CcSEcCtD
Mitomycin—Dermatitis—Bleomycin—skin cancer	0.000103	0.00148	CcSEcCtD
Mitomycin—Syncope—Docetaxel—skin cancer	0.000101	0.00145	CcSEcCtD
Mitomycin—Leukopenia—Docetaxel—skin cancer	0.000101	0.00145	CcSEcCtD
Mitomycin—Body temperature increased—Fluorouracil—skin cancer	0.0001	0.00145	CcSEcCtD
Mitomycin—Asthenia—Temozolomide—skin cancer	9.89e-05	0.00143	CcSEcCtD
Mitomycin—Loss of consciousness—Docetaxel—skin cancer	9.87e-05	0.00142	CcSEcCtD
Mitomycin—Cough—Docetaxel—skin cancer	9.8e-05	0.00141	CcSEcCtD
Mitomycin—Nausea—Bleomycin—skin cancer	9.7e-05	0.0014	CcSEcCtD
Mitomycin—Hypertension—Docetaxel—skin cancer	9.69e-05	0.0014	CcSEcCtD
Mitomycin—Vomiting—Dactinomycin—skin cancer	9.69e-05	0.0014	CcSEcCtD
Mitomycin—Rash—Dactinomycin—skin cancer	9.61e-05	0.00138	CcSEcCtD
Mitomycin—Diarrhoea—Temozolomide—skin cancer	9.43e-05	0.00136	CcSEcCtD
Mitomycin—Confusional state—Docetaxel—skin cancer	9.24e-05	0.00133	CcSEcCtD
Mitomycin—Oedema—Docetaxel—skin cancer	9.16e-05	0.00132	CcSEcCtD
Mitomycin—Dizziness—Temozolomide—skin cancer	9.11e-05	0.00131	CcSEcCtD
Mitomycin—Nausea—Dactinomycin—skin cancer	9.05e-05	0.0013	CcSEcCtD
Mitomycin—Shock—Docetaxel—skin cancer	9.02e-05	0.0013	CcSEcCtD
Mitomycin—Thrombocytopenia—Docetaxel—skin cancer	8.97e-05	0.00129	CcSEcCtD
Mitomycin—Vomiting—Temozolomide—skin cancer	8.76e-05	0.00126	CcSEcCtD
Mitomycin—Anorexia—Docetaxel—skin cancer	8.73e-05	0.00126	CcSEcCtD
Mitomycin—Rash—Temozolomide—skin cancer	8.69e-05	0.00125	CcSEcCtD
Mitomycin—Diarrhoea—Fluorouracil—skin cancer	8.69e-05	0.00125	CcSEcCtD
Mitomycin—Dermatitis—Temozolomide—skin cancer	8.68e-05	0.00125	CcSEcCtD
Mitomycin—Headache—Temozolomide—skin cancer	8.63e-05	0.00124	CcSEcCtD
Mitomycin—Dizziness—Fluorouracil—skin cancer	8.4e-05	0.00121	CcSEcCtD
Mitomycin—Nausea—Temozolomide—skin cancer	8.18e-05	0.00118	CcSEcCtD
Mitomycin—Dyspnoea—Docetaxel—skin cancer	8.17e-05	0.00118	CcSEcCtD
Mitomycin—Somnolence—Docetaxel—skin cancer	8.15e-05	0.00117	CcSEcCtD
Mitomycin—Vomiting—Fluorouracil—skin cancer	8.07e-05	0.00116	CcSEcCtD
Mitomycin—Rash—Fluorouracil—skin cancer	8e-05	0.00115	CcSEcCtD
Mitomycin—Dermatitis—Fluorouracil—skin cancer	8e-05	0.00115	CcSEcCtD
Mitomycin—Decreased appetite—Docetaxel—skin cancer	7.97e-05	0.00115	CcSEcCtD
Mitomycin—Headache—Fluorouracil—skin cancer	7.95e-05	0.00115	CcSEcCtD
Mitomycin—Fatigue—Docetaxel—skin cancer	7.9e-05	0.00114	CcSEcCtD
Mitomycin—Pain—Docetaxel—skin cancer	7.84e-05	0.00113	CcSEcCtD
Mitomycin—Feeling abnormal—Docetaxel—skin cancer	7.55e-05	0.00109	CcSEcCtD
Mitomycin—Nausea—Fluorouracil—skin cancer	7.54e-05	0.00109	CcSEcCtD
Mitomycin—Body temperature increased—Docetaxel—skin cancer	7.24e-05	0.00104	CcSEcCtD
Mitomycin—Asthenia—Docetaxel—skin cancer	6.57e-05	0.000948	CcSEcCtD
Mitomycin—Diarrhoea—Docetaxel—skin cancer	6.27e-05	0.000904	CcSEcCtD
Mitomycin—Dizziness—Docetaxel—skin cancer	6.06e-05	0.000874	CcSEcCtD
Mitomycin—Vomiting—Docetaxel—skin cancer	5.83e-05	0.00084	CcSEcCtD
Mitomycin—Rash—Docetaxel—skin cancer	5.78e-05	0.000833	CcSEcCtD
Mitomycin—Dermatitis—Docetaxel—skin cancer	5.77e-05	0.000832	CcSEcCtD
Mitomycin—Headache—Docetaxel—skin cancer	5.74e-05	0.000828	CcSEcCtD
Mitomycin—Nausea—Docetaxel—skin cancer	5.44e-05	0.000785	CcSEcCtD
